Petra Obrtlíková, MD

First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic

N/A

Poster(s):

• 1205 - Rituximab Maintenance after Chemoimmunotherapy Induction in 1st and 2nd Line Improves Progression Free Survival: Long Term Follow up of the International Randomized AGMT-CLL8/a Mabtenance Trial